PhenylpiracetamNootropic derivative of piracetam CAS# 77472-70-9 |
- Metformin HCl
Catalog No.:BCC4799
CAS No.:1115-70-4
- Lenalidomide (CC-5013)
Catalog No.:BCC2245
CAS No.:191732-72-6
- Gliclazide
Catalog No.:BCC5002
CAS No.:21187-98-4
- Geniposide
Catalog No.:BCN5104
CAS No.:24512-63-8
- MEK inhibitor
Catalog No.:BCC1738
CAS No.:334951-92-7
- Imeglimin hydrochloride
Catalog No.:BCC4085
CAS No.:775351-61-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 77472-70-9 | SDF | Download SDF |
| PubChem ID | 132441 | Appearance | Powder |
| Formula | C12H14N2O2 | M.Wt | 218.25 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | 25℃: DMSO | ||
| Chemical Name | 2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide | ||
| SMILES | C1C(CN(C1=O)CC(=O)N)C2=CC=CC=C2 | ||
| Standard InChIKey | LYONXVJRBWWGQO-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C12H14N2O2/c13-11(15)8-14-7-10(6-12(14)16)9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,13,15) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Phenylpiracetam Dilution Calculator
Phenylpiracetam Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.5819 mL | 22.9095 mL | 45.819 mL | 91.638 mL | 114.5475 mL |
| 5 mM | 0.9164 mL | 4.5819 mL | 9.1638 mL | 18.3276 mL | 22.9095 mL |
| 10 mM | 0.4582 mL | 2.291 mL | 4.5819 mL | 9.1638 mL | 11.4548 mL |
| 50 mM | 0.0916 mL | 0.4582 mL | 0.9164 mL | 1.8328 mL | 2.291 mL |
| 100 mM | 0.0458 mL | 0.2291 mL | 0.4582 mL | 0.9164 mL | 1.1455 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Description: IC50 Value: N/A Phenylpiracetam is a phenylated derivative of the nootropic drug piracetam. It is used as astimulant nootropic drug that can be up to 30-60 times more potent than piracetam. in vitro: N/A in vivo: In the open-field test, a significant increase in locomotor activity was observed after a single administration of R-phenotropil at doses of 10 and 50 mg/kg and S-phenotropil at a dose of 50 mg/kg. In the forced swim test, R-phenotropil induced an antidepressant effect at doses of 100 and 50 mg/kg, and S-phenotropil was active at a dose of 100 mg/kg. R-phenotropil significantly enhanced memory function in a passive avoidance response test at a dose of 1 mg/kg; the S-enantiomer did not show any activity in this test [1]. Toxicity: N/A Clinical trial: N/A
- Pimobendan hydrochloride
Catalog No.:BCC4175
CAS No.:77469-98-8
- KM 11060
Catalog No.:BCC7578
CAS No.:774549-97-2
- 5-Androsten-3β-ol-17-one ethyleneketal
Catalog No.:BCC8738
CAS No.:7745-40-6
- Episesartemin A
Catalog No.:BCN7239
CAS No.:77449-31-1
- Sesartemin
Catalog No.:BCN4779
CAS No.:77394-27-5
- Drimiopsin D
Catalog No.:BCN4326
CAS No.:773850-91-2
- Drimiopsin C
Catalog No.:BCN4325
CAS No.:773850-90-1
- Triacetylpseurotin A
Catalog No.:BCN6916
CAS No.:77353-57-2
- Acamprosate calcium
Catalog No.:BCC1327
CAS No.:77337-73-6
- Hyuganin D
Catalog No.:BCN7679
CAS No.:77331-76-1
- SL 0101-1
Catalog No.:BCC8086
CAS No.:77307-50-7
- Hirsutine
Catalog No.:BCN2758
CAS No.:7729-23-9
- DL-m-Tyrosine
Catalog No.:BCC3332
CAS No.:775-06-4
- PTC124 (Ataluren)
Catalog No.:BCC3881
CAS No.:775304-57-9
- Imeglimin hydrochloride
Catalog No.:BCC4085
CAS No.:775351-61-6
- Imeglimin
Catalog No.:BCC4221
CAS No.:775351-65-0
- Corylifol A
Catalog No.:BCN3198
CAS No.:775351-88-7
- Corylifol B
Catalog No.:BCN3199
CAS No.:775351-90-1
- Corylifol C
Catalog No.:BCN3200
CAS No.:775351-91-2
- (20R)-Protopanaxdiol
Catalog No.:BCN1078
CAS No.:7755-01-3
- Ingenol-5,20-acetonide
Catalog No.:BCN2960
CAS No.:77573-43-4
- Ingenol-3,4:5,20-diacetonide
Catalog No.:BCN2959
CAS No.:77573-44-5
- Nestoron
Catalog No.:BCC1797
CAS No.:7759-35-5
- Isoscopoletin
Catalog No.:BCN4582
CAS No.:776-86-3
[Pharmacological characteristics of a new phenyl analog of piracetam--4-phenylpiracetam].[Pubmed:6403074]
Biull Eksp Biol Med. 1983 Apr;95(4):50-3.
The central neurotropic effects of 4-phenylpyracetam, a new phenyl analog of pyracetam, were studied and compared with the effects of pyracetam, morpholene and 4-phenylpyrrolidone. 4-Phenylpyracetam was found to activate the operant behavior more powerfully, to remove psychodepressant effects of diazepam, to inhibit post-rotational nystagmus, and to prevent the development of retrograde amnesia. Unlike pyracetam, 4-phenylpyracetam exhibits a specific anticonvulsant action. When given in high doses, the compound under study produces psychodepressant effects.
